Extendicare Inc. (TSE:EXE – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$10.12 and traded as high as C$13.35. Extendicare shares last traded at C$13.06, with a volume of 305,519 shares changing hands.
Analysts Set New Price Targets
Several equities analysts have commented on EXE shares. TD Securities raised their price objective on Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research report on Monday, March 3rd. Royal Bank of Canada lifted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. BMO Capital Markets lifted their price target on Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd. Finally, Cormark raised Extendicare to a “moderate buy” rating in a research report on Wednesday, February 19th.
View Our Latest Analysis on EXE
Extendicare Trading Up 1.0 %
Extendicare Announces Dividend
The company also recently declared a monthly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 17th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.68%. Extendicare’s dividend payout ratio is currently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- How to find penny stocks to invest and tradeĀ
- Can TikTok Stock Picks Really Make You Rich?
- Buy P&G Now, Before It Sets A New All-Time High
- The “Quality” Rotation: Back to Basics Investing
- What Are Growth Stocks and Investing in Them
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.